US EditionQ&A: Tariffs put MedTech innovation at risk and open door to
Summary by MobiHealthNews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Q&A: Tariffs put MedTech innovation at risk and open door to
Marcel Botha, CEO and founder of 10XBeta, a MedTech innovation firm and venture studio, joined MobiHealthNews to discuss the widespread and unintended consequences of tariffs imposed by the Trump Administration on the MedTech supply chain.Botha states that these tariffs will impact not only final medical products but also critical components and subassemblies, thereby hindering the ability of U.S.-based manufacturers to operate efficiently. Mobi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
